Marta Freitas Costa (Marta Costa)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Systematic Review

Renal Cell Carcinoma

Cell Proliferation

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Fábio Pedroso de Lima, Marta Freitas Costa, Ana Sousa, Maria Fernanda Proença
The Chromenopyridine Scaffold: A Privileged Platform in Drug Design. Molecules (Basel, Switzerland) 29 (13) (2024)
Luísa Carvalho, Fábio Pedroso de Lima, Mónica Cerqueira, Ana Silva, Olívia Pontes, Sofia Oliveira-Pinto, Sara R Guerreiro, Marta Daniela Costa, Sara Granja, Patrícia Maciel, Adhemar Longatto-Filho, Fátima Baltazar, Fernanda Proença, Marta Freitas Costa
In vitro and in vivo evaluation of novel chromeno[2,3- d ]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC medicinal chemistry 15 (4) (2024)
Fábio Pedroso de Lima, Marta Freitas Costa, Ana Sousa, Maria Fernanda Proença
The Chromenopyridine Scaffold: A Privileged Platform in Drug Design. Molecules (Basel, Switzerland) 29 (13) (2024)
Luísa Carvalho, Fábio Pedroso de Lima, Mónica Cerqueira, Ana Silva, Olívia Pontes, Sofia Oliveira-Pinto, Sara R Guerreiro, Marta Daniela Costa, Sara Granja, Patrícia Maciel, Adhemar Longatto-Filho, Fátima Baltazar, Fernanda Proença, Marta Freitas Costa
In vitro and in vivo evaluation of novel chromeno[2,3- d ]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC medicinal chemistry 15 (4) (2024)
Ana Silva, Mónica Costa Cerqueira, Beatriz Rosa, Catarina Sobral, Filipa Lacerda Pinto-Ribeiro, Marta Freitas Costa, Fátima Baltazar, Julieta Afonso
Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International journal of molecular sciences 24 (6) (2023)
Julieta Afonso, Céline S Gonçalves, Marta Freitas Costa, Débora Ferreira, Lúcio Santos, Adhemar Longatto-Filho, Fátima Baltazar
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy. Cancers 15 (3) (2023)
Ana Silva, Mónica Costa Cerqueira, Beatriz Rosa, Catarina Sobral, Filipa Lacerda Pinto-Ribeiro, Marta Freitas Costa, Fátima Baltazar, Julieta Afonso
Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International journal of molecular sciences 24 (6) (2023)
Julieta Afonso, Céline S Gonçalves, Marta Freitas Costa, Débora Ferreira, Lúcio Santos, Adhemar Longatto-Filho, Fátima Baltazar
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy. Cancers 15 (3) (2023)
Ana Silva, Mónica Costa Cerqueira, Beatriz Rosa, Catarina Sobral, Filipa Lacerda Pinto-Ribeiro, Marta Freitas Costa, Fátima Baltazar, Julieta Afonso
Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International journal of molecular sciences 24 (6) (2023)
Ana Sofia Freitas, Marta Freitas Costa, Olívia Pontes, Veronique Seidel, Fernanda Proença, Susana M Cardoso, Rui Oliveira, Fátima Baltazar, Cristina Almeida-Aguiar
Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells. Molecules (Basel, Switzerland) 27 (13) (2022)